Lanean...
Biomarkers predictive of survival and response to immune checkpoint inhibitors (ICI) in melanoma
Immunotherapy has revolutionized the treatment of melanoma. Targeting of the immune checkpoints cytotoxic T-lymphocyte-associated protein 4 and programmed cell death protein 1 has led to improved survival in a subset of patients. Unfortunately, the use of immune checkpoint inhibitors is associated w...
Gorde:
| Argitaratua izan da: | Am J Clin Dermatol |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6994371/ https://ncbi.nlm.nih.gov/pubmed/31602560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40257-019-00475-1 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|